Laboratory Tests of Thyroid Function: Uses and Limitations

Endocrinology and Metabolism Clinics of North America

Volumn 36, Issue 3, 2007, Pages 579-594

  Dufour, D Robert ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCITONIN; RHEUMATOID FACTOR; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN;

CALCITONIN BLOOD LEVEL; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; THYROGLOBULIN BLOOD LEVEL; THYROID DISEASE; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

CALCITONIN; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 34547207181     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2007.04.003     Document Type: Review

References (50)

1. Spencer C., Takeuchi M., Kazarosyan M., et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83 (1998) 1121-1127
2. Despres N., and Grant A. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem 44 (1998) 440-454
3. Mariotti S., Barbesino G., Caturegli P., et al. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?. J Clin Endocrinol Metab 80 (1995) 468-472
4. Preissner C., O'Kane D., Singh R., et al. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 88 (2003) 3069-3074
5. Kricka L. Human anti-animal antibody interferences in immunological assays. Clin Chem 45 (1999) 942-956
6. Reinsberg J. Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay. Clin Biochem 29 (1996) 145-148
7. Ismail A., Walker P., Barth J., et al. Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem 48 (2002) 2023-2029
8. Klee G. Interferences in hormone immunoassays. Clin Lab Med 24 (2004) 1-18
9. Demers L., and Spencer C. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13 (2003) 3-126
10. Vanderpump M., Tunbridge W., French J., et al. The incidence of thyroid disorders in the community: a twenty year follow up of the Wickham survey. Clin Endocrinol (Oxf) 43 (1995) 55-68
11. Hollowell J., Staehling N., Flanders W., et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87 (2002) 489-499
12. Surks M., Ortiz E., Daniels G., et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291 (2004) 228-238
13. Steele B., Wang E., Klee G., et al. Analytic bias of thyroid function tests: analysis of a College of American Pathologists fresh frozen serum pool by 3900 clinical laboratories. Arch Pathol Lab Med 129 (2005) 310-317
14. Spencer C., Elgen A., Shen D., et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 33 (1987) 1391-1396
15. Attia J., Margetts P., and Guyatt G. Diagnosis of thyroid disease in hospitalized patients: a systematic review. Arch Intern Med 159 (1999) 658-665
16. Persani L., Boragato S., Romoli R., et al. Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J Clin Endocrinol Metab 83 (1998) 2486-2492
17. Persani L., Ferretti E., Boragato S., et al. Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85 (2000) 3631-3635
18. McDermott M., and Ridgeway E. Central hypothyroidism. Endocrinol Metab Clin North Am 27 (1998) 187-203
19. Sapin R., d'Herbomez M., Schlienger J., et al. Anti-thyrotropin antibody interference in thyrotropin assays. Clin Chem 44 (1998) 2557-2559
20. Halsall D., Fahie-Wilson M., Hall S., et al. Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother. Clin Chem 52 (2006) 1968-1969
21. Steele B., Wang E., Palmer-Toy D., et al. Total long-term within-laboratory precision of cortisol, ferritin, thyroxine, free thyroxine, and thyroid-stimulating hormone assays based on a college of American pathologists fresh frozen serum study: do available methods meet medical needs for precision?. Arch Pathol Lab Med 129 (2005) 318-322
22. Faix J., Rosen H., and Velazquez F. Indirect estimation of thyroid hormone-binding proteins to calculate free thyroxine index: comparison of nonisotopic methods that use labeled thyroxine ("T-uptake"). Clin Chem 41 (1995) 41-47
23. Konno N., Hirokawa J., Tsuji M., et al. Concentration of free thyroxin in serum during nonthyroidal illness: calculation or measurement?. Clin Chem 35 (1989) 159-163
24. Csako G., Zweig M., Glickman J., et al. Direct and indirect techniques for free thyroxin compared in patients with nonthyroidal illness: II. Effect of prealbumin, albumin, and thyroxin-binding globulin. Clin Chem 35 (1989) 1655-1662
25. Ritter D., Brown W., Nahm M., et al. Endogenous serum antibodies that interfere with a common thyroid hormone uptake assay: characterization and prevalence. Clin Chem 40 (1994) 1940-1943
26. Stockigt J. Free thyroid hormone measurement: a critical appraisal. Endocrinol Metab Clin North Am 30 (2001) 265-289
27. Holm S., Hansen S., Faber J., et al. Reference methods for the measurement of free thyroid hormones in blood: evaluation of potential reference methods for free thyroxine. Clin Biochem 37 (2004) 85-93
28. Soldin S., Soukhova N., Janicic N., et al. The measurement of free thyroxine by isotope dilution tandem mass spectrometry. Clin Chim Acta 358 (2005) 113-118
29. Wong T., Pekary A., Hoo G., et al. Comparison of methods for measuring free thyroxin in nonthyroidal illness. Clin Chem 38 (1992) 720-724
30. Ross H., and Benraad T. Is free thyroxine accurately measurable at room temperature?. Clin Chem 38 (1992) 880-886
31. Midgley J. Direct and indirect free thyroxine assay methods: theory and practice. Clin Chem 47 (2001) 1352-1363
32. Sapin R., and d'Herbomez M. Free thyroxine measured by equilibrium dialysis and nine immunoassays in sera with various serum thyroxine-binding capacities. Clin Chem 49 (2003) 1531-1535
33. Wang E., Nelson J., Weiss R., et al. Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins. Thyroid 10 (2000) 31-39
34. Surks M., and Sievert R. Drugs and thyroid function. N Engl J Med 333 (1995) 1688-1694
35. Martinetti A., Seregni E., Ferrari L., et al. Evaluation of circulating calcitonin: analytical aspects. Tumori 89 (2003) 566-568
36. Saller B., Gorges R., Reinhardt W., et al. Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease. Clin Lab 48 (2002) 191-200
37. Karanikas G., Moameni A., Poetzi C., et al. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89 (2004) 515-519
38. Karges W., Dralle H., Raue F., et al. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112 (2004) 52-58
39. American Association of Clinical Endocrinologists and Associazone Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12 (2006) 63-102
40. Castro M., and Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med 142 (2005) 926-931
41. Hodak S., and Burman K. The calcitonin conundrum: is it time for routine measurement of serum calcitonin in patients with thyroid nodules?. J Clin Endocrinol Metab 89 (2004) 511-514
42. Druetta L., Croizet K., Bornet H., et al. Analyses of the molecular forms of serum thyroglobulin from patients with Graves' disease, subacute thyroiditis or differentiated thyroid cancer by velocity sedimentation on sucrose gradient and Western blot. Eur J Endocrinol 139 (1998) 498-507
43. Spencer C., and Wang C. Thyroglobulin measurement: techniques, clinical benefits, and pitfalls. Endocrinol Metab Clin North Am 24 (1995) 841-863
44. Wunderlich G., Zophel K., Crook L., et al. A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin. Thyroid 11 (2001) 819-824
45. Bourrel F., Hoff M., Regis H., et al. Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests. Clin Chem Lab Med 36 (1998) 725-730
46. Wood W., and Hanke R. Comparability of method results and performance in a national external quality assessment scheme between 1993 and 2003 using thyroid associated antibodies as examples. Clin Lab 50 (2004) 209-221
47. Bohuslavizki K., vom Baur E., Weger B., et al. Evaluation of chemiluminescence immunoassays for detecting thyroglobulin (Tg) and thyroid peroxidase (TPO) autoantibodies using the IMMULITE 2000 system. Clin Lab 46 (2000) 22-31
48. Jensen E., Petersen P., Blaabjerg O., et al. Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb). Clin Chem Lab Med 44 (2005) 991-998
49. Cubero J., Rodriguez-Espinosa J., Gelpi C., et al. Thyroglobulin autoantibody levels below the cut-off for positivity can interfere with thyroglobulin measurement. Thyroid 13 (2003) 659-661
50. Chiovato L., Latrofa F., Braverman L., et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139 (2003) 346-351